NOT-MH-21-136: Notice of Extension to PA-18-566, "Complex Technologies and Therapeutics Development for Mental Health Research and Practice (R43/R44 Clinical Trial Optional)"

Notice of Extension to PA-18-566, "Complex Technologies and Therapeutics Development for Mental Health Research and Practice (R43/R44 Clinical Trial Optional)"

Notice Number:

NOT-MH-21-136

Key Dates

Release Date:

December 21, 2020

Related Announcements

PA-18-566 - Complex Technologies and Therapeutics Development for Mental Health Research and Practice (R43/R44 Clinical Trial Optional)

Issued by

National Institute of Mental Health (NIMH)

Purpose

This Notice extends the expiration date for PA-18-566, "Complex Technologies and Therapeutics Development for Mental Health Research and Practice (R43/R44 Clinical Trial Optional)". The dates have been modified to add one additional receipt date.

Changes to Key Dates apply to Part 1. Overview Information, Key Dates.

Current Expiration Date: January 6, 2021.

New Expiration Date: April 6, 2021.

Changes are reflected in italics as follows:

Part 1. Overview Information

Key Dates

Currently reads:

Expiration Date

January 6, 2021

Modified to read (in italics)

Part 1. Overview Information,

Key Dates

Expiration Date

April 6, 2021

All other aspects of of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

[email protected]

Refer to the FOA for specific research contacts